US · EVMN
Evommune, Inc.
- Sector
- Healthcare · Biotechnology
- Headquarters
- Palo Alto, CA 94304
- Website
- evommune.com
Price · as of 2026-09-03
$12.00
Market cap 184.42M
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $21.99 | $17.74 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Growth | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| EVMN | Evommune, Inc. | $14.08 | 184.42M | $17.74 | +26% | -10.07 | 3.37 | 53.32 | -8.09 | 85.71% |
| ARTV | Artiva Biotherapeutics, I… | $11.27 | 278.56M | — | — | -1.80 | 1.37 | — | -0.66 | -100.00% |
| CDXS | Codexis, Inc. | $1.47 | 133.58M | $14.63 | +896% | -3.19 | 2.78 | 1.99 | -4.00 | 18.61% |
| CLYM | Climb Bio, Inc. | $14.00 | 801.68M | — | — | -7.97 | 2.97 | — | -6.30 | — |
| EYPT | EyePoint Pharmaceuticals,… | $13.89 | 1.16B | $11.09 | -20% | -4.17 | 3.16 | 30.82 | -2.98 | -27.50% |
| FTRE | Fortrea Holdings Inc. | $18.43 | 1.75B | $8.22 | -55% | -0.83 | 1.45 | 0.30 | -2.16 | 1.00% |
| KPTI | Karyopharm Therapeutics I… | $2.12 | 48.05M | $8.51 | +301% | -0.44 | -0.29 | 0.59 | -1.71 | 0.57% |
| LGND | Ligand Pharmaceuticals In… | $293.15 | 5.88B | $238.03 | -19% | 31.53 | 3.86 | 14.64 | 18.90 | 60.40% |
| OABI | OmniAb, Inc. | $3.08 | 366.8M | $13.59 | +341% | -3.14 | 0.76 | 10.90 | -3.81 | -29.27% |
| ZYME | Zymeworks Inc. | $23.54 | 1.73B | $116.79 | +396% | -21.25 | 6.42 | 16.27 | -22.04 | 38.87% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($17.74 ÷ $12.00) − 1 = +47.83% (IC, example).